Longitude (Cayman) Ltd. Amicus Therapeutics, Inc. Call Options Transaction History

Longitude (Cayman) Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 08, 2022	SELL	$9.82 - $12.75 $594,110 - $771,375	-60,500 Reduced 75.16%	20,000 $209,000
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $339,535 - $606,040	54,500 Added 209.62%	80,500 $865,000
Q1 2022 May 12, 2022	SELL	$7.89 - $12.48 $1.77 Million - $2.8 Million	-224,000 Reduced 89.6%	26,000 $246,000
Q2 2021 Aug 10, 2021	BUY	$8.71 - $10.72 $99,294 - $122,208	11,400 Added 4.78%	250,000 $2.41 Million
Q1 2021 May 11, 2021	BUY	$9.2 - $23.86 $2.2 Million - $5.69 Million	238,600 New	238,600 $2.36 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Longitude (Cayman) Ltd., based on Form 13F filings with the SEC.

Stay updated on Longitude (Cayman) Ltd. with notifications on news.